Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream.
Segura
Sonia
S
Romero
David
D
Carrera
Cristina
C
Iranzo
Pilar
P
Estrach
Teresa
T
D000287:Administration, Topical; D000328:Adult; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007617:Kaposi Varicelliform Eruption / Q000150:complications / Q000276:immunology / Q000473:pathology*; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D009824:Ointments; C117268:pimecrolimus; D016559:Tacrolimus